Plant Advanced Technologies (ALPAT) Stock Overview
A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
ALPAT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Plant Advanced Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €7.08 |
| 52 Week High | €11.50 |
| 52 Week Low | €6.34 |
| Beta | 0.75 |
| 1 Month Change | -15.71% |
| 3 Month Change | -16.11% |
| 1 Year Change | -34.44% |
| 3 Year Change | -42.20% |
| 5 Year Change | -69.22% |
| Change since IPO | -46.36% |
Recent News & Updates
Shareholder Returns
| ALPAT | FR Biotechs | FR Market | |
|---|---|---|---|
| 7D | -12.6% | 2.3% | -1.0% |
| 1Y | -34.4% | 350.8% | -2.2% |
Return vs Industry: ALPAT underperformed the French Biotechs industry which returned 324.6% over the past year.
Return vs Market: ALPAT underperformed the French Market which returned -2.1% over the past year.
Price Volatility
| ALPAT volatility | |
|---|---|
| ALPAT Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in FR Market | 11.1% |
| 10% least volatile stocks in FR Market | 2.6% |
Stable Share Price: ALPAT has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: ALPAT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 16 | Jean-Paul Fevre | www.plantadvanced.com |
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.
Plant Advanced Technologies SA Fundamentals Summary
| ALPAT fundamental statistics | |
|---|---|
| Market cap | €7.94m |
| Earnings (TTM) | €935.13k |
| Revenue (TTM) | €2.22m |
Is ALPAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALPAT income statement (TTM) | |
|---|---|
| Revenue | €2.22m |
| Cost of Revenue | €527.46k |
| Gross Profit | €1.69m |
| Other Expenses | €752.56k |
| Earnings | €935.13k |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.83 |
| Gross Margin | 76.19% |
| Net Profit Margin | 42.22% |
| Debt/Equity Ratio | 37.4% |
How did ALPAT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/12 09:46 |
| End of Day Share Price | 2026/03/12 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Plant Advanced Technologies SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charles-Louis Planade | TPICAP Midcap |
| Florent Thy-Tine | TPICAP Midcap |
| Claire Deray | TPICAP Midcap |